Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Other Non Operating Income (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Other Non Operating Income data on record, last reported at $223000.0 in Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 2127.27% year-over-year to $223000.0; the TTM value through Sep 2025 reached $768000.0, up 6500.0%, while the annual FY2024 figure was $153000.0, 563.64% up from the prior year.
  • Other Non Operating Income reached $223000.0 in Q3 2025 per SNTI's latest filing, up from $187000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $223000.0 in Q3 2025 and bottomed at -$1.3 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is -$41333.3, with a median of -$4000.0 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: plummeted 1300.91% in 2022, then skyrocketed 3016.67% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $110000.0 in 2021, then tumbled by 1300.91% to -$1.3 million in 2022, then surged by 99.47% to -$7000.0 in 2023, then surged by 2357.14% to $158000.0 in 2024, then skyrocketed by 41.14% to $223000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $223000.0 in Q3 2025, $187000.0 in Q2 2025, and $200000.0 in Q1 2025.